Esperion Therapeutics Aktie
2,25
EUR
-0,09
EUR
-3,69
%
2,71
USD
+0,04
USD
+1,50
%
Werbung
Esperion Therapeutics Aktie Analyse
| 07.01.19 | Esperion Therapeutics Strong Buy | Needham & Company, LLC | |
| 16.10.18 | Esperion Therapeutics Buy | BTIG Research | |
| 27.03.18 | Esperion Therapeutics Neutral | Chardan Capital Markets | |
| 21.02.18 | Esperion Therapeutics Strong Buy | Needham & Company, LLC | |
| 17.01.18 | Esperion Therapeutics Buy | UBS AG | |
| 14.12.17 | Esperion Therapeutics Strong Buy | Needham & Company, LLC | |
| 06.12.17 | Esperion Therapeutics Neutral | Chardan Capital Markets | |
| 27.06.17 | Esperion Therapeutics Buy | Stifel, Nicolaus & Co., Inc. | |
|
Werbung
|
|||
| 23.06.17 | Esperion Therapeutics Buy | Deutsche Bank AG | |
| 30.03.17 | Esperion Therapeutics Buy | UBS AG | |
| 23.02.17 | Esperion Therapeutics Sector Perform | RBC Capital Markets | |
| 05.07.16 | Esperion Therapeutics Hold | WallachBeth | |
| 30.06.16 | Esperion Therapeutics Buy | Needham & Company, LLC | |
| 29.06.16 | Esperion Therapeutics Sector Perform | RBC Capital Markets | |
| 26.02.16 | Esperion Therapeutics Neutral | Chardan Capital Markets | |
| 25.02.16 | Esperion Therapeutics Buy | Stifel, Nicolaus & Co., Inc. | |
| 15.12.15 | Esperion Therapeutics Outperform | RBC Capital Markets | |
| 26.10.15 | Esperion Therapeutics Buy | Lake Street | |
| 26.10.15 | Esperion Therapeutics Buy | WallachBeth | |
| 29.09.15 | Esperion Therapeutics Sell | Chardan Capital Markets | |
| 31.08.15 | Esperion Therapeutics Sell | Chardan Capital Markets | |
| 19.08.15 | Esperion Therapeutics Buy | Needham & Company, LLC | |
| 10.08.15 | Esperion Therapeutics Strong Buy | Needham & Company, LLC | |
| 07.08.15 | Esperion Therapeutics Sell | Chardan Capital Markets | |
| 31.07.15 | Esperion Therapeutics Sell | Chardan Capital Markets | |
| 27.07.15 | Esperion Therapeutics Sell | Chardan Capital Markets | |
| 08.07.15 | Esperion Therapeutics Sell | Chardan Capital Markets | |
| 10.06.15 | Esperion Therapeutics Sell | Chardan Capital Markets | |
| 22.05.15 | Esperion Therapeutics Sell | Chardan Capital Markets | |
| 21.05.15 | Esperion Therapeutics overweight | Barclays Capital | |
| 08.05.15 | Esperion Therapeutics Buy | Needham & Company, LLC | |
| 08.05.15 | Esperion Therapeutics Buy | Stifel, Nicolaus & Co., Inc. | |
| 23.04.15 | Esperion Therapeutics Outperform | RBC Capital Markets | |
| 01.04.15 | Esperion Therapeutics Buy | UBS AG | |
| 06.03.15 | Esperion Therapeutics Buy | Needham & Company, LLC | |
| 17.02.15 | Esperion Therapeutics Buy | Stifel, Nicolaus & Co., Inc. | |
| 27.10.14 | Esperion Therapeutics Buy | Needham & Company, LLC | |
Werbung
Werbung